11月21日，开开实业盘中下跌2.06%，截至10:09，报14.28元/股，成交1.53亿元，换手率6.56%，总市值 37.51亿元。 资金流向方面，主力资金净流出1055.20万元，特大单买入0.00元，占比0.00%，卖出648.79万元，占比 4.24%；大单买入2197.28万元，占比14.36%，卖出2603.69万元，占比17.01%。 开开实业所属申万行业为：医药生物-医药商业-医药流通。所属概念板块包括：SPD概念、民营医院、 小盘、中药、医药电商等。 截至9月30日，开开实业股东户数3.37万，较上期减少7.03%；人均流通股0股，较上期增加0.00%。2025 年1月-9月，开开实业实现营业收入8.25亿元，同比增长10.76%；归母净利润1286.78万元，同比减少 62.81%。 分红方面，开开实业A股上市后累计派现1.91亿元。近三年，累计派现3474.90万元。 机构持仓方面，截止2025年9月30日，开开实业十大流通股东中，招商证券(香港)有限公司位居第三大 流通股东，持股113.11万股，持股数量较上期不变。BOCI SECURITIES LIMITED位居第七大流通股 东 ...

Core Viewpoint - LQ Group Co., Ltd. has experienced a decline in stock price and financial performance in 2023, indicating potential challenges in its retail operations and market conditions [2]. Financial Performance - As of November 21, LQ Group's stock price decreased by 2.12% to 4.61 CNY per share, with a market capitalization of 4.213 billion CNY [1]. - Year-to-date, the stock price has dropped by 8.55%, with a 2.74% decline over the last five trading days [2]. - For the period from January to September 2025, the company reported a revenue of 5.365 billion CNY, a year-on-year decrease of 4.83%, and a net profit attributable to shareholders of 13.7355 million CNY, down 46.79% year-on-year [2]. Shareholder Information - As of September 30, the number of shareholders increased to 28,900, a rise of 1.42%, while the average circulating shares per person decreased by 1.40% to 31,594 shares [2]. Business Operations - LQ Group's main business segments include retail chain operations (68.92% of revenue), logistics supply chain (28.44%), food industry (2.52%), and other businesses (0.11%) [2]. - The company is categorized under the general retail sector, with concepts including community group buying, low-price strategies, prepared dishes, small-scale operations, and new retail [2]. Dividend Distribution - Since its A-share listing, LQ Group has distributed a total of 811 million CNY in dividends, with 127 million CNY distributed over the past three years [3].

Core Viewpoint - The stock of Furuida has experienced a decline, with a current price of 7.75 yuan per share and a market capitalization of 7.878 billion yuan, reflecting a challenging financial performance in recent periods [1][2]. Company Performance - Furuida's stock price has increased by 3.33% year-to-date, but it has seen a decline of 3.00% over the last five trading days, 1.77% over the last 20 days, and 9.57% over the last 60 days [1]. - For the period from January to September 2025, Furuida reported a revenue of 2.597 billion yuan, a year-on-year decrease of 7.34%, and a net profit attributable to shareholders of 142 million yuan, down 17.19% year-on-year [2]. Shareholder and Market Activity - As of September 30, 2025, Furuida had 44,500 shareholders, a decrease of 6.27% from the previous period, with an average of 22,827 circulating shares per shareholder, an increase of 6.69% [2]. - The company has made cumulative cash distributions of 1.196 billion yuan since its A-share listing, with 213 million yuan distributed over the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders, the Southern CSI 1000 ETF holds 4.6498 million shares, having decreased its holdings by 70,900 shares compared to the previous period [3].

Core Viewpoint - Tianjian Group's stock price has shown volatility, with a recent decline of 2.13% and a total market capitalization of 7.717 billion yuan, reflecting mixed investor sentiment and market conditions [1]. Financial Performance - For the period from January to September 2025, Tianjian Group reported a revenue of 9.959 billion yuan, representing a year-on-year growth of 7.79%. However, the net profit attributable to shareholders was 20.129 million yuan, a significant decrease of 93.87% compared to the previous year [2]. Stock Market Activity - As of November 21, Tianjian Group's stock price was 4.13 yuan per share, with a trading volume of 1.01 billion yuan and a turnover rate of 1.29%. The stock has increased by 2.99% year-to-date but has seen a decline of 6.98% over the last five trading days [1]. - The net outflow of main funds was 5.6256 million yuan, with large orders showing a buy of 18.65% and a sell of 23.02% [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Tianjian Group was 41,400, a decrease of 0.98% from the previous period. The average circulating shares per person increased by 0.99% to 45,081 shares [2]. - The company has cumulatively distributed 4.909 billion yuan in dividends since its A-share listing, with 1.252 billion yuan distributed over the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 15.4975 million shares, a decrease of 5.9438 million shares from the previous period. Other notable changes include an increase in holdings by E Fund CSI Dividend ETF and a new entry by Fortune CSI Dividend Index Enhanced A/B [3].

Core Viewpoint - The stock of Sanyuan Foods has experienced fluctuations, with a recent decline of 2.17% and a year-to-date increase of 23.06%, indicating volatility in its market performance [1]. Financial Performance - For the period from January to September 2025, Sanyuan Foods reported a revenue of 4.871 billion yuan, a year-on-year decrease of 9.74%, while the net profit attributable to shareholders increased by 128.16% to 236 million yuan [2]. - The company has distributed a total of 317 million yuan in dividends since its A-share listing, with 104 million yuan distributed in the last three years [3]. Stock Market Activity - As of November 21, Sanyuan Foods' stock price was 5.40 yuan per share, with a market capitalization of 8.111 billion yuan. The stock has seen a trading volume of 139 million yuan and a turnover rate of 1.69% [1]. - The company has appeared on the "龙虎榜" (a list of stocks with significant trading activity) three times this year, with the most recent appearance on November 14, where it recorded a net buy of -127.629 million yuan [1]. Shareholder Information - As of September 30, 2025, Sanyuan Foods had 31,300 shareholders, a decrease of 9.19% from the previous period, with an average of 47,776 circulating shares per shareholder, an increase of 10.12% [2]. - Notable institutional holdings include Hong Kong Central Clearing Limited as the sixth-largest shareholder, increasing its stake by 1.4604 million shares, and Guangfa Quantitative Multi-Factor Mixed A as a new ninth-largest shareholder with 4.2951 million shares [3].

Group 1 - The core viewpoint of the news is that Anada's stock has experienced a decline recently, with a notable drop of 2.08% on November 21, 2023, and a total market value of 4.275 billion yuan [1] - Anada's stock price has increased by 4.17% year-to-date, but it has seen declines of 7.74% over the last five trading days, 5.80% over the last twenty days, and 11.82% over the last sixty days [1] - The company has been featured on the "龙虎榜" (a stock trading list) seven times this year, with the most recent appearance on May 20, 2023, where it recorded a net buy of -8.117 million yuan [1] Group 2 - Anada's main business involves the research, production, and sales of electric drive systems for electric two-wheelers, with revenue composition being 82.50% from hub motors, 10.17% from mid-mounted motors, 6.79% from controllers and others, and 0.54% from other sources [1] - As of September 30, 2023, Anada had 12,900 shareholders, an increase of 4.89% from the previous period, with an average of 3,399 circulating shares per person, up by 44.64% [2] - For the period from January to September 2023, Anada achieved operating revenue of 1.597 billion yuan, a year-on-year increase of 34.10%, and a net profit attributable to shareholders of 96.0565 million yuan, up by 13.05% [2] Group 3 - Anada has distributed a total of 145 million yuan in dividends since its A-share listing [3]

Core Viewpoint - The stock price of Di Rui Medical has experienced a significant decline this year, with a drop of 16.23% year-to-date and a 2.95% decrease over the past 20 days, indicating potential challenges in the company's performance and market perception [2]. Company Overview - Di Rui Medical Technology Co., Ltd. is located in Changchun, Jilin Province, and was established on December 26, 1994. The company was listed on September 10, 2014. Its main business involves the research, production, and sales of medical testing instruments and related test paper reagents [2]. - The revenue composition of Di Rui Medical is as follows: reagents account for 57.13%, instruments for 42.24%, and other sources for 0.63% [2]. - The company operates within the pharmaceutical and biological industry, specifically in the medical device sector focusing on in vitro diagnostics. It is associated with several concept sectors, including small-cap stocks, hepatitis treatment, monkeypox concepts, medical devices, and Sino-Russian trade [2]. Financial Performance - For the period from January to September 2025, Di Rui Medical reported a revenue of 469 million yuan, representing a year-on-year decrease of 60.12%. The net profit attributable to the parent company was -87.25 million yuan, reflecting a significant decline of 145.31% compared to the previous year [2]. - As of September 30, 2025, the company had a total of 16,800 shareholders, a decrease of 6.48% from the previous period. The average number of circulating shares per shareholder increased by 6.92% to 16,159 shares [2]. Shareholder and Dividend Information - Di Rui Medical has distributed a total of 923 million yuan in dividends since its A-share listing, with 340 million yuan distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders included a new entrant, Dachen Jingheng Mixed A (090019), holding 1.27 million shares, ranking as the ninth largest circulating shareholder [3].

Core Viewpoint - Changhua Group's stock has experienced fluctuations, with a year-to-date increase of 27.78% but a recent decline in the last five trading days by 5.48% [1] Group 1: Stock Performance - As of November 21, Changhua Group's stock price was 11.03 CNY per share, with a market capitalization of 5.185 billion CNY [1] - The stock has seen a trading volume of 8.2925 million CNY, with a turnover rate of 0.16% [1] - The stock has appeared on the "Dragon and Tiger List" five times this year, with the most recent net purchase on June 5 amounting to 17.1875 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Changhua Group reported a revenue of 1.502 billion CNY, a year-on-year decrease of 9.46% [2] - The net profit attributable to shareholders was 60.9323 million CNY, reflecting a year-on-year decline of 32.28% [2] Group 3: Shareholder Information - As of November 10, the number of shareholders for Changhua Group was 16,300, a decrease of 0.44% from the previous period [2] - The average number of tradable shares per shareholder increased by 0.44% to 28,831 shares [2] - The company has distributed a total of 470 million CNY in dividends since its A-share listing, with 251 million CNY distributed in the last three years [3]

Core Viewpoint - The stock of Caidi Industrial has experienced a decline of 2.10% on November 21, with a current price of 18.67 CNY per share, despite a year-to-date increase of 30.47% [1] Group 1: Stock Performance - As of November 21, Caidi Industrial's stock price is 18.67 CNY, with a trading volume of 760.76 million CNY and a turnover rate of 0.79%, resulting in a total market capitalization of 2.166 billion CNY [1] - The stock has seen a decline of 7.57% over the past five trading days, a slight increase of 1.52% over the last 20 days, and a minimal increase of 0.21% over the last 60 days [1] Group 2: Company Overview - Caidi Industrial, established on December 5, 2002, is located in the industrial park of Lianxi Avenue, Lianxi Town, Nanxun District, Huzhou City, Zhejiang Province [1] - The company was listed on March 16, 2023, and its main business includes the research, production, and sales of polyester fabrics, seamless garments, and polyester filaments, along with entrusted dyeing and finishing processing [1] - The revenue composition of the main business is as follows: polyester fabrics 58.03%, entrusted dyeing and finishing 17.71%, seamless garments 15.78%, others 6.26%, and polyester filaments 2.22% [1] Group 3: Financial Performance - For the period from January to September 2025, Caidi Industrial achieved an operating income of 592 million CNY, representing a year-on-year growth of 6.20%, while the net profit attributable to the parent company was 62.88 million CNY, a decrease of 4.72% year-on-year [1] - As of September 30, 2025, the number of shareholders is 9,678, a decrease of 3.24% from the previous period, with an average of 5,258 circulating shares per person, an increase of 3.35% [1] Group 4: Shareholder Information - Since its A-share listing, Caidi Industrial has distributed a total of 104 million CNY in dividends [2] - As of September 30, 2025, among the top ten circulating shareholders, CITIC Prudential Multi-Strategy Mixed Fund (LOF) A is the tenth largest shareholder with 521,100 shares, marking its entry as a new shareholder, while Nuoan Multi-Strategy Mixed Fund A has exited the top ten list [2]

Core Viewpoint - Amway Co., Ltd. has experienced a decline in stock price and financial performance, with a notable drop in revenue and net profit for the first nine months of 2025 compared to the previous year [2][3]. Financial Performance - As of November 10, 2025, Amway Co., Ltd. reported a revenue of 1.679 billion yuan, a decrease of 6.84% year-on-year, and a net profit attributable to shareholders of 121 million yuan, down 19.22% year-on-year [2]. - The company's stock price has increased by 9.74% year-to-date but has seen a decline of 10.45% over the last five trading days, 4.54% over the last 20 days, and 22.69% over the last 60 days [1]. Shareholder Information - As of November 10, 2025, the number of shareholders increased to 18,400, up 8.63% from the previous period, while the average circulating shares per person decreased by 7.95% to 11,729 shares [2]. - The company has distributed a total of 341 million yuan in dividends since its A-share listing, with 131 million yuan distributed in the last three years [3]. Ownership Structure - As of September 30, 2025, new institutional shareholders include Yongying Advanced Manufacturing Mixed Fund and China Europe Enjoy Life Mixed Fund, while several funds exited the top ten circulating shareholders list [3].